Harvard Bioscience Return on Tangible Equity 2010-2023 | HBIO

Current and historical return on tangible equity values for Harvard Bioscience (HBIO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Harvard Bioscience Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.00B $0.00B 1200.00%
2023-09-30 $-0.00B $0.00B 200.00%
2023-06-30 $-0.01B $0.00B 166.67%
2023-03-31 $-0.00B $-0.00B 53.33%
2022-12-31 $-0.01B $-0.01B 200.00%
2022-09-30 $-0.01B $-0.01B 164.71%
2022-06-30 $-0.00B $-0.00B 72.73%
2022-03-31 $-0.01B $-0.01B 82.76%
2021-12-31 $0.00B $-0.00B 0.00%
2021-09-30 $-0.00B $-0.01B 16.67%
2021-06-30 $-0.00B $-0.01B 22.64%
2021-03-31 $-0.01B $-0.01B 33.90%
2020-12-31 $-0.01B $-0.02B 56.25%
2020-09-30 $-0.01B $-0.02B 44.44%
2020-06-30 $-0.01B $-0.02B 53.73%
2020-03-31 $-0.01B $-0.02B 40.00%
2019-12-31 $-0.00B $-0.01B 21.92%
2019-09-30 $-0.00B $-0.02B 10.13%
2019-06-30 $0.00B $-0.02B -4.88%
2019-03-31 $0.00B $-0.02B 0.00%
2018-12-31 $-0.00B $-0.02B 8.25%
2018-09-30 $-0.00B $-0.02B 36.36%
2018-06-30 $-0.00B $-0.03B 533.33%
2018-03-31 $-0.00B $-0.03B -28.57%
2017-12-31 $0.00B $0.03B 0.00%
2017-09-30 $-0.00B $0.02B -11.76%
2017-06-30 $-0.00B $0.02B -24.62%
2017-03-31 $-0.01B $0.02B -31.75%
2016-12-31 $-0.01B $0.02B -31.75%
2016-09-30 $-0.02B $0.02B -133.33%
2016-06-30 $-0.02B $0.02B -103.90%
2016-03-31 $-0.02B $0.02B -83.52%
2015-12-31 $-0.02B $0.02B -75.25%
2015-09-30 $-0.00B $0.03B -6.72%
2015-06-30 $0.00B $0.03B 0.00%
2015-03-31 $0.00B $0.03B 2.78%
2014-12-31 $0.00B $0.03B 7.59%
2014-09-30 $0.00B $0.04B 4.91%
2014-06-30 $0.00B $0.04B 0.00%
2014-03-31 $-0.00B $0.04B -2.25%
2013-12-31 $-0.00B $0.04B -4.32%
2013-09-30 $0.00B $0.05B 0.00%
2013-06-30 $0.00B $0.05B 2.19%
2013-03-31 $0.00B $0.05B 4.62%
2012-12-31 $0.00B $0.05B 7.36%
2012-09-30 $0.00B $0.04B 7.74%
2012-06-30 $0.00B $0.04B 7.95%
2012-03-31 $0.00B $0.04B 7.84%
2011-12-31 $0.00B $0.04B 10.46%
2011-09-30 $0.01B $0.04B 13.42%
2011-06-30 $0.02B $0.04B 50.00%
2011-03-31 $0.02B $0.04B 59.84%
2010-12-31 $0.02B $0.03B 67.26%
2010-09-30 $0.02B $0.03B 84.00%
2010-06-30 $0.01B $0.02B 42.35%
2010-03-31 $0.01B $0.02B 28.87%
2009-12-31 $0.01B $0.02B 25.93%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71